title: Postprandial peptide YY release is mediated by cholecystokinin.
abstract: Peptide YY (PYY), a 36 amino acid peptide, is a member of the structurally and functionally related pancreatic polypeptide (PP) family of gastrointestinal and neurally active peptides. Peptide YY is released postprandially from the distal small intestine and colon and has been shown to inhibit many physiologic actions of cholecystokinin (CCK), an integral foregut hormonal stimulant of pancreatic and gastric secretion. The specific signals for the release of PYY have not been ascertained, although foregut signals, both neural and hormonal, are likely. In this study, we evaluated the possible role for CCK in postprandial PYY release in eight conscious dogs. Conscious dogs were given a fat meal or a one hour intravenous infusion of CCK-8. On separate days, the dogs were pretreated with the specific CCK receptor antagonist L-364,718. Peripheral blood samples were collected for radioimmunoassay for PYY, PP and neuropeptide Y. The fat meal and exogenous CCK stimulated PYY and PP release, effects that were abolished by pretreatment with the CCK receptor antagonist. The results provide support for a physiologic role of CCK in the mediation of postprandial PYY and PP release. Furthermore, an inhibitory feedback loop is suggested between the hindgut (PYY) and the foregut (CCK).
authors.affiliation: Department of Surgery, University of Cincinnati College of Medicine, Ohio 45267-0558.
authors.forename: D W
authors.initials: DW
authors.lastname: McFadden
authors.forename: M
authors.initials: M
authors.lastname: Rudnicki
authors.forename: B
authors.initials: B
authors.lastname: Kuvshinoff
authors.forename: J E
authors.initials: JE
authors.lastname: Fischer
mesh_terms: D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology; D002766:Cholecystokinin / Q000037:antagonists & inhibitors / Q000502:physiology*; D003106:Colon / Q000378:metabolism; D020109:Devazepide; D004041:Dietary Fats / Q000008:administration & dosage; D004285:Dogs; D004435:Eating / Q000502:physiology*; D005246:Feedback / Q000502:physiology; D005768:Gastrointestinal Hormones / Q000378:metabolism*; D007421:Intestine, Small / Q000378:metabolism; D009478:Neuropeptide Y / Q000378:metabolism; D010191:Pancreatic Polypeptide / Q000378:metabolism; D019894:Peptide YY; D010455:Peptides / Q000378:metabolism*; D011863:Radioimmunoassay
chemical_list: D001570:Benzodiazepinones; D004041:Dietary Fats; D005768:Gastrointestinal Hormones; D009478:Neuropeptide Y; D010455:Peptides; D019894:Peptide YY; D010191:Pancreatic Polypeptide; D002766:Cholecystokinin; D020109:Devazepide